Results 231 to 240 of about 98,914 (278)

Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale

, 2015
Napasri Chaisinanunkul, Opeolu Adeoye, Roger Lewis, James C. Grotta, Joseph P. Broderick, Tudor G. Jovin, Raul G. Nogueira, Jordan Elm, Todd Graves, Scott Berry, Kennedy R. Lees, Andrew D. Barreto, Jeffrey L. Saver, Anthony J. Furlan, Blaise Baxter, Helmi L. Lutsep, Marc Ribó, Olav Jansen, Rishi Gupta, Vítor Mendes Pereira   +19 more
openalex   +1 more source

Prognostic Factors of Functional Outcome Assessed by Using the Modified Rankin Scale in Subacute Ischemic Stroke. [PDF]

J Clin Med Res, 2019
Kongsawasdi S, Klaphajone J, Wivatvongvana P, Watcharasaksilp K.   +3 more
europepmc   +1 more source

Treatment effect on ordinal functional outcome using piecewise multistate Markov model with unobservable baseline: an application to the modified Rankin scale. [PDF]

J Biopharm Stat, 2019
Cassarly C, Martin RH, Chimowitz M, Peña EA, Ramakrishnan V, Palesch YY.   +5 more
europepmc   +1 more source

Comparative interrater reliability of Asian Stroke Disability Scale, modified Rankin Scale and Barthel Index in patients with brain infarction.

, 2012
Kavian Ghandehari, K Ghandehari, Ghazaleh Saffarian-Toosi, Shahram Masoudinezhad, Siamak Yazdani, Ali Nooraddin, Saeed Ebrahimzadeh, Fahimeh Ahmadi, Fatemeh Abrishamchi   +8 more
openalex   +1 more source

Data used for the analysis of distribution of modified Rankin Scale (mRS) scores at 90 days post-stroke.

Chun-Hsien Lin (21144406), Meng Lee (433817), Bruce Ovbiagele (458478), David S. Liebeskind (9030908), Borja Sanz-Cuesta (21144409), Jeffrey L. Saver (5696642)   +5 more
openalex   +1 more source

A comparison of statistical techniques used in the longitudinal analysis of the modified Rankin scale in stroke randomised controlled trials [PDF]

, 2018
Jessica Potts
openalex  

Some of the next articles are maybe not open access.

Related searches:

Validation of the Simplified Modified Rankin Scale Questionnaire

European Neurology, 2020
<b><i>Introduction:</i></b> The modified Rankin scale (mRS) is the most common assessment tool for measuring overall functional outcome in stroke studies. The traditional way of using mRS face-to-face is time- and cost-consuming. The aim of this study was to test the validity of the Swedish translation of the simplified modified
Eva Isaksson, Per Wester, Ann Charlotte Laska, Per Näsman, Erik Lundström   +4 more
openaire   +2 more sources

Modified Rankin scale assessment by telephone using a simple questionnaire

Journal of Stroke and Cerebrovascular Diseases, 2022
The modified Rankin Scale (mRS) is widely used as a measure of post-stroke physical disability in clinical stroke trials; however, it is affected by inter-rater discrepancies. A Japanese version of the simplified mRS questionnaire (J-RASQ) has the potential to overcome the inter-rater discrepancies and might be feasible for clinical surveys.
Kenichiro, Yi, Makoto, Nakajima, Tomoaki, Ikeda, Mineko, Yoshigai, Mitsuharu, Ueda   +4 more
openaire   +2 more sources

Properties of Proxy-Derived Modified Rankin Scale Assessment

International Journal of Stroke, 2012
Background Cognitive or communication issues may preclude direct modified Rankin Scale interview, necessitating interview with a suitable surrogate. The clinimetric properties of this proxy modified Rankin Scale assessment have not been described. Aims To describe reliability of proxy-derived modified Rankin Scale and compare with traditional direct ...
Kate, McArthur, Michael L C, Beagan, Andrew, Degnan, Rosanne C, Howarth, Kirsten A, Mitchell, Fiona B, McQuaige, Mary Ann C, Shannon, D J, Stott, Terence J, Quinn   +8 more
openaire   +2 more sources

Retrospective collection of 90-day modified Rankin Scale is accurate

Clinical Trials, 2020
Background: The 90-day modified Rankin Scale is a widely used outcome after stroke but is sometimes hard to ascertain due to loss to follow-up. Missing outcomes can result in biased and/or inefficient estimates in clinical trials. The aim of this study is to assess the validity of acquiring the 90-day modified Rankin Scale at a later point of time when
Mengxi Wang, Suja S Rajan, Asha P Jacob, Noopur Singh, Stephanie A Parker, Ritvij Bowry, James C Grotta, Jose-Miguel Yamal   +7 more
openaire   +2 more sources